Total Wealth Planning & Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$475K Sell
1,815
-9,197
-84% -$2.36M 0.35% 94
2026
Q2
$2.77M Sell
11,012
-1,841
-14% -$396K 1.87% 4
2026
Q1
$2.8M Buy
12,853
+96
+0.8% +$21.3K 2.06% 3
2025
Q4
$2.91M Buy
+12,757
New +$2.91M 2.16% 6
2025
Q2
$2.7M Sell
14,538
-59
-0.4% -$11K 2.19% 4
2025
Q1
$3.06M Sell
14,597
-122
-0.8% -$23.7K 2.9% 1
2024
Q4
$2.62M Buy
+14,719
New +$2.71M 2.37% 4

Other funds holding ABBV

Total Wealth Planning & Management's ABBV Position: Q3 2026 in Review

Total Wealth Planning & Management reduced its AbbVie (ABBV) stake by 84% in Q3 2026, selling an estimated $2.36M and leaving 1,815 shares worth $475K. The position accounts for 0.35% of the portfolio, ranked #94.

Total Wealth Planning & Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.06M in Q1 2025. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Total Wealth Planning & Management held 1,815 shares of AbbVie worth $475K as of Q3 2026.
  • Total Wealth Planning & Management sold 9,197 AbbVie shares in Q3 2026, an estimated $2.36M.
  • AbbVie made up 0.35% of Total Wealth Planning & Management's portfolio in Q3 2026, its #94 holding.
  • Total Wealth Planning & Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Total Wealth Planning & Management's AbbVie position peaked at $3.06M in Q1 2025.
  • 1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Total Wealth Planning & Management's 13F filing for Q3 2026, filed 23 Oct 2026.